International Society for Pharmacoeconomics and Outcomes Research ( ISPOR )

ISPOR

International Society for Pharmacoeconomics and Ou...'s picture

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) promotes the science of pharmacoeconomics (health economics) and outcomes research (the scientific discipline that evaluates the effect of health care interventions on patient well-being including clinical, economic, and patient-centered outcomes) and facilitates the translation of this research into useful information for health care decision makers to increase the efficiency, effectiveness, and fairness of health care to improve health. Founded in 1995, ISPOR is a non-profit 501(c)(3) public organization for educational and scientific purposes, as defined by the US IRS, and a non-profit research organization under the European Commission 7th Framework Programme.

ISPOR press release, blog etc

04/09/2018 - 06:48 ISPOR Announces Honorees for 2018 Awards Program
04/03/2018 - 08:21 Study: Real-World Evidence has Limited Use in Managed Care Formulary Decision Making
03/27/2018 - 04:11 New Drugs and Medical Technologies Often Deemed Cost-Effective but Unaffordable
03/19/2018 - 07:43 New Training Programs in Health Economics and Outcomes Research Announced
03/13/2018 - 15:11 Conference Theme and Plenary Speakers Announced for ISPOR 2018
03/06/2018 - 08:42 New Top 10 Trends in Health Economics and Outcomes Research Webinar Announced
02/27/2018 - 07:50 New Study Shows Most Women Willing to Accept the Risks of Breast Screening
02/26/2018 - 07:31 ISPOR Special Task Force Provides Recommendations for Measuring and Communicating the Value of Pharmaceuticals and Other Technologies in the US
02/13/2018 - 10:59 ISPOR Announces a Brand Refresh for the Society
02/06/2018 - 12:58 , the professional society for health economics and outcomes research (HEOR), announced today the release of its
02/06/2018 - 11:59 Top 10 Trends Driving Healthcare in 2018
01/22/2018 - 19:39 ISPOR Announces Appointment of New Associate Chief Science Officer
01/16/2018 - 18:57 ISPOR Updates Its Code of Ethics
01/10/2018 - 18:20 ISPOR Establishes New Patient Council
01/02/2018 - 09:35 High-Risk Medical Devices Granted European Licensure Based on Low-Quality Evidence
12/20/2017 - 13:17 Removal of Drug Coverage Caps Associated With Improved Medication Persistence
11/21/2017 - 06:42 ISPOR Honored With 6 Stevie Awards for Women in Business
11/21/2017 - 05:16 , the professional society for health economics and outcomes research, was honored with 6 prestigious awards at the 14th Annual